<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62218">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02295943</url>
  </required_header>
  <id_info>
    <org_study_id>2014/879</org_study_id>
    <nct_id>NCT02295943</nct_id>
  </id_info>
  <brief_title>Objective Evaluation of Postoperative Positioning in Macular Hole Surgery</brief_title>
  <official_title>Objective Evaluation of Postoperative Positioning in Macular Hole Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helse Stavanger HF</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Trondheim University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helse Stavanger HF</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The macular hole formation takes place in the centre of the retina. A closure of the macular
      hole is believed to take place if the central retinal area is kept dry in the postoperative
      period. Therefore the eye is filled with a gas mix and the patients are urged to avoid the
      supine position in the first postoperative days. The investigators have developed a
      positioning measuring device which can measure the extent of supine positioning time.
      Patients are to carry the positioning measuring device during the first postoperative 24
      hours. Hereby the investigators search new knowledge concerning patients compliance and its
      relation to macular hole closure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Macular hole closure</measure>
    <time_frame>1 month or more after enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time in supine sleeping position</measure>
    <time_frame>1 day after enrollment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Macular Hole</condition>
  <arm_group>
    <arm_group_label>Positioning measuring device</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The supine time during the first postoperative day is measured</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Positioning measuring device</intervention_name>
    <description>Vitrectomy, intraocular gas fill. The supine time during the first postoperative day is measured</description>
    <arm_group_label>Positioning measuring device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary macular hole

          -  Duration less than 24 months

          -  Informed consent

        Exclusion Criteria:

          -  Secondary macular hole i.e. trauma, excessive myopia (more than 6 dioptres)

          -  Previous vitreomacular surgery

          -  Age under 18 years

          -  Unable to sign
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vegard Forsaa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stavanger University Hospital, Department of Ophthalmology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vegard Forsaa, MD</last_name>
    <phone>+47 47902397</phone>
    <email>vegard.forsaa@sus.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joergen Krohn, PhD</last_name>
      <email>jorgen.krohn@helse-bergen.no</email>
    </contact>
    <investigator>
      <last_name>Joergen Krohn, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paal Varhaug, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stavanger University Hospital</name>
      <address>
        <city>Stavanger</city>
        <zip>4011</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vegard Forsaa, MD</last_name>
      <email>vegard.forsaa@sus.no</email>
    </contact>
    <investigator>
      <last_name>Vegard Forsaa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laila Hashemi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of North Norway</name>
      <address>
        <city>Tromsoe</city>
        <zip>9038</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristian Fossen, MD</last_name>
      <email>kristian.fossen@unn.no</email>
    </contact>
    <investigator>
      <last_name>Kristian Fossen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ole Harald Helgesen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Trondheim University Hospital</name>
      <address>
        <city>Trondheim</city>
        <zip>7030</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dordi Austeng, PhD</last_name>
      <email>Dordi.Austeng@stolav.no</email>
    </contact>
    <investigator>
      <last_name>Dordi Austeng, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sammy Basit, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <lastchanged_date>November 16, 2015</lastchanged_date>
  <firstreceived_date>November 17, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
